News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
MINNEAPOLIS, Jan. 24, 2019 /PRNewswire/ — Bio-Techne announces the launch of their cell and gene therapy portfolio. As a leading manufacturer of GMP-grade ancillary materials and automated instrumentation, Bio-Techne is uniquely able to offer solutions that advance the translation of cell and gene therapies, from discovery-level research to the optimization of cell therapy manufacturing unit... Read more
January 22, 2019 09:04 AM Pacific Standard Time OXFORD, England–(BUSINESS WIRE)–Today the European Patent Office revoked Pacific Biosciences patent EP3045542 with claims to a single molecule sequencing process wherein two strands of DNA are linked by a connecting nucleic acid. The validity of the patent had been challenged by Oxford Nanopore. The EPO ruled that... Read more
(ANN ARBOR, Mich. – January 16, 2019) Swift Biosciences today announced the launch of its Swift Amplicon 16S+ITS Panel, facilitating routine NGS analysis of complex microbial samples (e.g. bacteria, archaea, fungi) using a single, multiplexed primer pool targeting the 16S rRNA gene (all variable regions, V1-V9) and ITS1 and ITS2 for fungi. With a comprehensive... Read more
Consortium leverages DNAnexus cloud-based platform to scale genome assembly and improve quality for the maize population January 08, 2019 08:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, the global leader in genome informatics and data management, today announced details of its collaboration with Dawe lab from University of Georgia, Hufford lab from Iowa State... Read more
Ann Arbor, Michigan (January 7, 2019) – Swift Biosciences, Inc. a manufacturer of precision next-generation sequencing (NGS) solutions, announces it has received International Organization Standardization (ISO) 13485:2016 certification for design, development, production, and distribution of molecular biology and related reagents in both standard and custom formats has been assessed and approved by National Quality assurance,... Read more
January 07, 2019 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced it has expanded its product portfolio to offer genes up to five kilobases (5kb) in length at industry-leading pricing. In addition, Twist is making its... Read more
Hilden, Germany, and Germantown, Maryland, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the development of a range of next-generation systems for digital polymerase chain reaction (digital PCR or dPCR), one of the fastest-growing molecular testing applications in the life sciences industry. QIAGEN expects to launch a fully integrated... Read more
Hilden, Germany, and Germantown, Maryland, January 7, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAcube Connect, which marks the next generation of QIAGEN’s widely used QIAcube instrument and is designed to bring the benefits of automated sample processing solution to a new level. QIAcube Connect offers greatly enhanced... Read more
–Subsidiary of BGI Group Will Distribute CleanPlex® NGS Target Enrichment Panels Optimized for Its MGISEQ and BGISEQ Sequencing Platforms in All Territories Outside the U.S.– –Paragon Genomics Will Distribute MGI’s Automated Sample Preparation Systems in the U.S. and Canada with Optimized CleanPlex Chemistries Providing a Complete Automated Solution– HAYWARD, CA – January 6, 2019 –... Read more
Date: 01/03/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Christine A. Tsingos has informed the company of her intention to retire as Executive Vice President and Chief Financial Officer effective April 30, 2019. Ms. Tsingos will remain in her current... Read more